South Korea In Vitro Diagnostics Market Insight
Published: 22 June 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The South Korea in vitro diagnostics market is expected to witness robust growth at a CAGR of 6.24% owing to rising chronic disease prevalence, increasing elderly demographics, reagent dominance, shift to chronic diseases.
South Korea In Vitro Diagnostics Market Insights Forecasts to 2035
- The South Korea In Vitro Diagnostics Market Size Was Estimated at USD 854.2 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.24% from 2025 to 2035
- The South Korea In Vitro Diagnostics Market Size is Expected to Reach around USD 1.56 Billion by 2035
Notable Insights for the South Korea In Vitro Diagnostics Market
- In South Korea, by 2025, Reagents and Kits will dominate the market at just under 56%. Due to an increase in clinical sample testing, Reagents and Kits will lead the way as a major component of the laboratory workflow.
- Application Wise, the Infectious Disease Diagnostic area will dominate with 61% of the total market in South Korea due to improved screening methods.
- SD Biosensor will generate 2.4 billion dollars in Global Revenue by FY 2025 as a result of increasing demand for Point of Care Testing configurations, Automated Assay Kits, and Diagnostic Tools.
- As expectations rise for AI-assisted diagnostics and Automated Lab Tracking Platforms, along with a drive for greater Assay Modernization, the market will continue to grow with specialized platforms achieving up to 46% improvement in Diagnostic Accuracy.
Download the eBook (ToC)
Research Methodologies Used to Analyze the South Korea In Vitro Diagnostics Market
In order to determine the size of the South Korean in vitro diagnostics market, we have utilized a blend of both primary and secondary research methodologies to create the most accurate data available regarding this industry and future projected trends. Primary research will be conducted through communication with manufacturers of medical diagnostic devices, laboratory users, pathology administrators and other members of the medical community to understand their consumer behaviors and pricing comparisons, as well as their competitive behaviors. Secondary research will include data obtained from publicly available sources such as reports published by private companies, government agencies, medical laboratory articles, world clinical trial registries, and diagnostics governing bodies. Using a combination of both market estimate, trend analysis, and forecasting methods will allow us to provide calculated estimates for the market size; potential growth opportunities; shifts in technology; and possible strategic investments in the health care sector.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea In Vitro Diagnostics Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea In Vitro Diagnostics Market
- SD Biosensor, Inc.
- Seegene, Inc.
- Macrogen, Inc.
- Sugentech, Inc.
- Boditech Med Inc.
- Osang Healthcare
- Bioneer Corporation
- Access Bio, Inc.
- PCL Inc.
- Humasis Co., Ltd.
Recent Developments:
- In February 2026, SD Biosensor expanded its molecular diagnostics portfolio with advanced automated analyzer systems designed for multiplex infectious disease detection and decentralized clinic usage.
- In September 2025, Seegene introduced next-generation high-throughput syndromic PCR assays integrated with cloud-based digital clinical optimization platforms for widespread regional healthcare laboratory networks.
Market Segmentation:
South Korea In Vitro Diagnostics Market, By Product Type
- Reagents
- Instruments
- Software Systems
- Point-of-Care Devices
- Tissue Diagnostics
South Korea In Vitro Diagnostics Market, By Technology
- Molecular Diagnostics (PCR)
- Clinical Chemistry
- Hematology Assays
South Korea In Vitro Diagnostics Market, By Application
- Infectious Diseases
- Oncology Testing
- Cardiology Screening
- Diabetes Monitoring
Expert Views:
In the future, in vitro diagnostics markets will continue their upward trend of growth through increased use of preventative healthcare, more municipal-level screening programs, and further implementation of automation in clinical settings. Improvements to efficiency through molecular based screening methods; cloud connected laboratory data and automated calibration procedures will create greater demand for these products as well as support the growth of interconnectivity between various healthcare systems.
Author: Govind and Krishna By Decisions Advisors and Consulting